How to license AI doctors
https://www.statnews.com/2026/05/11/ai-doctors-licenses-utah-doctronic-pilot/
Publish Date: 2026-05-11 04:31:00
Source Domain: www.statnews.com
- Utah’s AI Prescription Suspension: Utah’s Medical Licensing Board suspended a pilot program with AI company Doctronic due to lack of clinical oversight, highlighting potential risks to patients.
- State vs. Federal Regulatory Challenges: There is a fragmented regulatory landscape at the state level with over 250 bills considered, but the FDA’s traditional framework is ill-suited for adaptive AI.
- AI’s Clinical Potential: AI has shown significant improvements in medical tasks, indicating that autonomous AI can deliver competent care, especially in areas with physician shortages.
- Regulatory Shortcomings: The FDA’s rigid approval process for medical devices doesn’t adapt to continually improving AI systems, slowing down its deployment and acceptance.
- Adapting Licensing Model for AI: Proposed framework by Robert Wachter, Ezekiel Emanuel, and Alon Bergman outlines the four elements necessary to regulate autonomous clinical AI: demonstrated competency, defined scope of practice, ongoing monitoring, and federal oversight.
- Addressing Objections: The proposal addresses state concerns, equivalence with physicians, and the implementation capacity of the regulatory framework, emphasizing a national competency standard for AI.
- Need for Federal Framework: Without a coherent federal framework, regions with doctor shortages will continue lacking access to potentially beneficial AI technology while states struggle with ad hoc deployments and regulatory chaos.
- Call to Action for Congress: Urging Congress to establish a federal Office of Clinical AI Oversight to standardize regulation and provide a coherent approach to integrating AI into the healthcare system.
